Clinical and Prognostic Features of Erionite-Induced Malignant Mesothelioma.
10.3349/ymj.2015.56.2.311
- Author:
Ersin DEMIRER
1
;
Christian F GHATTAS
;
Mohamed O RADWAN
;
Elamin M ELAMIN
Author Information
1. Department of Thoracic Medicine, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
- Publication Type:Review
- Keywords:
Asbestos;
malignant mesothelioma;
pleural effusion
- MeSH:
Adult;
Asbestos/*adverse effects;
Asbestos, Amphibole;
Environmental Exposure/*adverse effects;
Female;
Humans;
Lung Neoplasms/*chemically induced/radiography;
Male;
Mesothelioma/*chemically induced/radiography;
Middle Aged;
Pleura/radiography;
Pleural Effusion/radiography;
Pleural Neoplasms/*chemically induced/radiography;
Prognosis;
Prospective Studies;
Retrospective Studies;
Tomography, X-Ray Computed;
Zeolites/*adverse effects
- From:Yonsei Medical Journal
2015;56(2):311-323
- CountryRepublic of Korea
- Language:English
-
Abstract:
This review analytically examines the published data for erionite-related malignant pleural mesothelioma (E-MPM) and any data to support a genetically predisposed mechanism to erionite fiber carcinogenesis. Adult patients of age > or =18 years with erionite-related pleural diseases and genetically predisposed mechanisms to erionite carcinogenesis were included, while exclusion criteria included asbestos- or tremolite-related pleural diseases. The search was limited to human studies though not limited to a specific timeframe. A total of 33 studies (31042 patients) including 22 retrospective studies, 6 prospective studies, and 5 case reports were reviewed. E-MPM developed in some subjects with high exposures to erionite, though not all. Chest CT was more reliable in detecting various pleural changes in E-MPM than chest X-ray, and pleural effusion was the most common finding in E-MPM cases, by both tests. Bronchoalveolar lavage remains a reliable and relatively less invasive technique. Chemotherapy with cisplatin and mitomycin can be administered either alone or following surgery. Erionite has been the culprit of numerous malignant mesothelioma cases in Europe and even in North America. Erionite has a higher degree of carcinogenicity with possible genetic transmission of erionite susceptibility in an autosomal dominant fashion. Therapeutic management for E-MPM remains very limited, and cure of the disease is extremely rare.
